Cargando…
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?
Myelodysplastic syndromes (MDS) are malignant hematopoietic stem cell disorders that have the capacity to progress to acute myeloid leukemia (AML). Accumulating evidence suggests that the altered bone marrow (BM) microenvironment in general, and in particular the components of the stem cell niche, i...
Autores principales: | Pleyer, Lisa, Valent, Peter, Greil, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964385/ https://www.ncbi.nlm.nih.gov/pubmed/27355944 http://dx.doi.org/10.3390/ijms17071009 |
Ejemplares similares
-
Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
por: Hoermann, Gregor, et al.
Publicado: (2020) -
Oral Mesenchymal Stem/Progenitor Cells: The Immunomodulatory Masters
por: Zhou, Li-li, et al.
Publicado: (2020) -
TET2 as an epigenetic master regulator for normal and malignant hematopoiesis
por: Nakajima, Hideaki, et al.
Publicado: (2014) -
Chipping in on clonal hematopoiesis
por: Gillis, Nancy K., et al.
Publicado: (2017) -
Evolution of clonal hematopoiesis
por: van Zeventer, Isabelle A., et al.
Publicado: (2023)